Avedro Announces Comprehensive Educational Schedule at ASCRS Annual Meeting
At the ASCRS Annual Meeting, there will be more than 80 presentations about corneal cross-linking and keratoconus, in addition to several educational events focused on corneal cross-linking and supported by
“We are excited by the sheer volume and quality of this year’s scientific sessions on corneal cross-linking,” said Reza Zadno, PhD, President and Chief Executive Officer (CEO) of
10:00-10:10 AM– US Clinical Update: The Future of Cross-Linking. Michael Raizman, MD. Booth #2506.
10:15-10:35 AM– Implementing CXL in a Private Practice. Brandon Ayres, MD & Clark Chang, OD. Booth #2506.
10:40-11:00 AM– Expert Panel: Implementing CXL in a Large Health System. Karolinne Maia Rocha, MD, PhD & Mohamed Abou Shousha, MD. Booth #2506.
11:15-11:30 AM– Conquering Cross-Linking Billing & Coding Challenges. John BerdahlMD & Janet Cox, CPC, Director of Billing & Coding, Vance Thompson Vision. Booth #2506.
3:00-3:15 PM– Collaborative Care in Cross-Linking. Dan Durrie, MD. Booth #2506.
3:20-3:30 PM– Understanding Your Insurance Contract. Mark Rosenberg, Practice Administrator Consultant & Bryan Ross, Practice Administrator; Tim Homer, Avedro VP of Global Health Policy, to moderate. Booth #2506.
6:00-7:50 PM– New Technologies in the Diagnosis & Treatment of Anterior Segment Diseases. Max Parikh, MD, Kathryn Hatch, MD, Jay Mattheis, MD, Nicole Fram, MD, and Raj Rajpal, MD as moderator. Reception and Program at Marriott Marquis San Diego, 333 W. Harbor Dr., San Diego. 10:00-10:15 AM– Complex Cases. John Sheppard, MD & Mark Milner, MD; Raj Rajpal, MD to moderate. Booth #2506.
10:20-10:40 AM– Expert Panel: Expanding Education for Diagnosing Providers. Ken Beckman, MD, Neda Shamie, MD, and Audrey Talley-Rostov, MD. Booth #2506.
10:45-11:00 AM– Expert Panel: What’s Important When Defining Progression? J. Bradley Randleman, MD & Russell Swan, MD; Edward Manche, MD to moderate. Booth #2506.
In addition to the above-noted programs, Avedro’s CEO,
12:05-12:35 PM– Traditional vs. Premium Channels: Who Pays and How? (Dr. Zadno) 2:20-3:05 PM– Postoperative Assessment of the Cornea – Current Approaches and Unmet Needs (Dr. Rajpal)
All educational content of the ASCRS Annual Meeting is planned by its program committee, and ASCRS does not endorse, promote, approve, or recommend the use of any products, devices, or services.
IMPORTANT SAFETY INFORMATION
Photrexa Viscous® (riboflavin 5’-phosphate in 20% dextran ophthalmic solution) and Photrexa® (riboflavin 5’-phosphate ophthalmic solution) are used with the KXL® System in corneal cross-linking to treat eyes in which the cornea, the clear dome-shaped surface that covers the front of the eye, has been weakened from the progression of the disease keratoconus or following refractive surgery, a method for correcting or improving your vision.
Tell your healthcare provider if you are pregnant or plan to become pregnant.
IMPORTANT SAFETY INFORMATION
Ulcerative keratitis, a potentially serious eye infection, can occur. Your doctor should monitor defects in the outermost corneal layer of the eye for resolution.
The most common ocular side effect is haze. Other ocular side effects include inflammation, fine white lines, dry eye, disruption of surface cells, eye pain, light sensitivity, reduced sharpness of vision, and blurred vision. The risk information provided here is not comprehensive. To learn more, talk to your healthcare provider.
Go to www.livingwithkeratoconus.com to obtain the
You are encouraged to report all side effects to the
Greg Chodaczek or Lynn Lewis
Source: Avedro, Inc